Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients.

PURPOSE To evaluate the impact of marker-based position verification, using daily imaging and an off-line correction protocol, by calculating the delivered dose to prostate, rectum and bladder. METHODS Prostate cancer patients (n=217) were treated with IMRT, receiving 35 daily fractions. Plans with five beams were optimized taking target coverage (CTV, boost) and organs-at-risk (rectum and bladder) into account. PTV margins were 8mm. Prostate position was verified daily using implanted fiducial gold markers by imaging the first segment of all the five beams on an EPID. Setup deviations were corrected off-line using an adapted shrinking-action-level protocol. The estimated delivered dose, including daily organ movements, was calculated using a version of PLATO's dose engine, enabling batch processing of large numbers of patients. The dose was calculated +/- inclusion of setup corrections, and was evaluated relative to the original static plan. The marker-based measurements were considered representative for all organs. RESULTS Daily organ movements would result in an underdosage of 2-3Gy to CTV and boost volume relative to the original plan, which was prevented by daily setup corrections. The dose to rectum and bladder was on average unchanged, but a large spread was introduced by organ movements, which was reduced by including setup corrections. CONCLUSIONS Without position verification and setup corrections, margins of 8mm would be insufficient to account for position uncertainties during IMRT of prostate cancer. With the daily off-line correction protocol, the remaining variations are accommodated adequately.

[1]  C C Ling,et al.  Cone-beam CT with megavoltage beams and an amorphous silicon electronic portal imaging device: potential for verification of radiotherapy of lung cancer. , 2002, Medical physics.

[2]  Chris Beltran,et al.  Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. , 2008, International journal of radiation oncology, biology, physics.

[3]  J. Kapatoes,et al.  Megavoltage CT image reconstruction during tomotherapy treatments. , 2000, Physics in medicine and biology.

[4]  Joos V Lebesque,et al.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Joos V Lebesque,et al.  Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. , 2002, International journal of radiation oncology, biology, physics.

[6]  M van Herk,et al.  Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. , 1995, International journal of radiation oncology, biology, physics.

[7]  D. Bostwick,et al.  Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. , 1996, International journal of radiation oncology, biology, physics.

[8]  A Bel,et al.  High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. , 1996, International journal of radiation oncology, biology, physics.

[9]  Randall K Ten Haken,et al.  Daily prostate targeting using implanted radiopaque markers. , 2001, International journal of radiation oncology, biology, physics.

[10]  Daniel W. Miller,et al.  Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. , 2005, JAMA.

[11]  Jake Van Dyk,et al.  Limitations of a convolution method for modeling geometric uncertainties in radiation therapy. II. The effect of a finite number of fractions. , 2003, Medical physics.

[12]  Jan J W Lagendijk,et al.  Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  M Goitein,et al.  Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution. , 1996, International journal of radiation oncology, biology, physics.

[14]  M. V. van Herk,et al.  The sensitivity of dose distributions for organ motion and set-up uncertainties in prostate IMRT. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  P J Keall,et al.  A fluence-convolution method to calculate radiation therapy dose distributions that incorporate random set-up error. , 2002, Physics in medicine and biology.

[16]  P Hofman,et al.  Feasibility of automatic marker detection with an a-Si flat-panel imager. , 2001, Physics in medicine and biology.

[17]  Eugene Wong,et al.  Dosimetric evaluation of daily rigid and nonrigid geometric correction strategies during on-line image-guided radiation therapy (IGRT) of prostate cancer. , 2006, Medical physics.

[18]  M. V. van Herk,et al.  The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[19]  Radhe Mohan,et al.  Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[20]  D. Johnston,et al.  Detailed mapping of prostate carcinoma foci , 2000, Cancer.

[21]  J. Battista,et al.  Limitations of a convolution method for modeling geometric uncertainties in radiation therapy. I. The effect of shift invariance. , 2003, Medical physics.

[22]  William Y Song,et al.  Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis. , 2006, International journal of radiation oncology, biology, physics.

[23]  T E Schultheiss,et al.  Can modest escalations of dose be detected as increased tumor control? , 1992, International journal of radiation oncology, biology, physics.

[24]  M. Herk.  Errors and margins in radiotherapy. , 2004 .

[25]  Marco van Vulpen,et al.  Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  K Lam,et al.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers. , 1995, International journal of radiation oncology, biology, physics.

[27]  J. Lagendijk,et al.  Partial boosting of prostate tumours. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  V. Budach,et al.  Influence of Organ at Risk Definition on Rectal Dose-Volume Histograms in Patients with Prostate Cancer Undergoing External-Beam Radiotherapy , 2006, Strahlentherapie und Onkologie.

[29]  Arjan Bel,et al.  Adequate margins for random setup uncertainties in head-and-neck IMRT. , 2005, International journal of radiation oncology, biology, physics.

[30]  T W Griffin,et al.  Cone-beam CT for radiotherapy applications. , 1995, Physics in medicine and biology.

[31]  Marcel van Herk,et al.  Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[32]  J C Stroom,et al.  Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. , 1999, International journal of radiation oncology, biology, physics.

[33]  D. Yan,et al.  Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? , 2002, International journal of radiation oncology, biology, physics.

[34]  P Hofman,et al.  Detection of fiducial gold markers for automatic on-line megavoltage position verification using a marker extraction kernel (MEK). , 2000, International journal of radiation oncology, biology, physics.

[35]  C. Fiorino,et al.  Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. , 2008, International journal of radiation oncology, biology, physics.

[36]  B. Heijmen,et al.  A new approach to off-line setup corrections: combining safety with minimum workload. , 2002, Medical physics.

[37]  Steve B. Jiang,et al.  Effects of motion on the total dose distribution. , 2004, Seminars in radiation oncology.

[38]  T Haycocks,et al.  Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  G J Kutcher,et al.  Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. , 2001, International journal of radiation oncology, biology, physics.

[40]  W. De Neve,et al.  Clinical implementation of electronic portal imaging: correction strategies and set-up errors. , 1996, Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique.

[41]  Jan J W Lagendijk,et al.  Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  B. Heijmen,et al.  Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  S Webb,et al.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. , 1993, Physics in medicine and biology.

[44]  George Starkschall,et al.  Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial , 2003 .

[45]  M. V. van Herk,et al.  A model to simulate day-to-day variations in rectum shape. , 2002, International journal of radiation oncology, biology, physics.